Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that deals/orders/contracts/projects/customers/sites/programs it is landing NOW are individually bigger, broader, or longer than before for the same offering? Look for a comparison against own past, already real and recurring, and early (not yet fully reflected). In the transcript, management discusses deal flow, pipeline, and investments. They mention "we continue to originate attractive investment opportunities and invested $70 million in new and existing portfolio companies at a weighted average yield of 12.6%." They talk about the JV growing. They mention "we are seeing an increase in deal flow compared to the first half of 2023 and have a growing pipeline of interesting and attractive investment opportunities." But that's about volume, not size per deal. They also mention "the JV closed a $300 million securitization" and "will allow the JV portfolio to grow to over $1 billion of assets." That's about the JV's capacity, not necessarily the size of individual deals. They talk about "the current vintage of middle market directly originated loans is excellent. Leverage is lower, spreads and upfront fees are higher and covenants are tighter." That's about terms, not size. They mention "we have a long-term track record of generating value by successfully financing high-growth middle market companies" and "we typically participate in the upside by making an equity co-investment." No mention of deal size escalation. They also discuss "the pipeline" and "deal flow" but not that each deal is bigger. They mention "we are seeing an increase in deal flow" - that's more volume. There is no statement like "the average size of our new investments has increased" or "our recent deals are larger than before." They talk about the JV growing, but that's about the JV's total assets, not individual deals. Also, they mention "we continue to originate attractive investment opportunities" and "invested $70 million" - that's a total, not per deal. The question asks specifically about successive engagements of the same kind coming in at progressively larger size. There is no such description. They talk about the pipeline being robust, but not that the deals are individually larger. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.